| Description: |
Several studies have been done to identify comorbidities of COVID‐19. In this work, we developed an analytical bioinformatics framework to reveal COVID‐19 comorbidities, their genomic associations, and molecular mechanisms accomplishing transcriptomic analyses of the RNA‐seq datasets provided by the Gene Expression Omnibus (GEO) database, where normal and infected tissues were evaluated. Using the framework, we identified 27 COVID‐19 correlated diseases out of 7,092 collected diseases. Analyzing clinical and epidemiological research, we noticed that our identified 27 diseases are associated with COVID‐19, where hypertension, diabetes, obesity, and lung cancer are observed several times in COVID‐19 patients. Therefore, we selected the above four diseases and performed assorted analyses to demonstrate the association between COVID‐19 and hypertension, diabetes, obesity, and lung cancer as comorbidities. We investigated genomic associations with the cross‐comparative analysis and Jaccard’s similarity index, identifying shared differentially expressed genes (DEGs) and linking DEGs of COVID‐19 and the comorbidities, in which we identified hypertension as the most associated illness. We also revealed molecular mechanisms by identifying statistically significant ten pathways and ten ontologies. Moreover, to understand cellular physiology, we did protein‐protein interaction (PPI) analyses among the comorbidities and COVID‐19. We also used the degree centrality method and identified ten biomarker hub proteins (IL1B, CXCL8, FN1, MMP9, CXCL10, IL1A, IRF7, VWF, CXCL9, and ISG15) that associate COVID‐19 with the comorbidities. Finally, we validated our findings by searching the published literature. Thus, our analytical approach elicited interconnections between COVID‐19 and the aforementioned comorbidities in terms of remarkable DEGs, pathways, ontologies, PPI, and biomarker hub proteins. |